(Bio-Scale, Mini Profinity IMAC cartrige, 732-4612, BIO-RAD) fitted to a AKTAprime plus purification system (GE Heathcare).
Overexpression of LasR ligand binding domain in E. coli BL21 (procedure for fishing experiments)
Electrocompetent E. coli BL21 cells were transfected with pET 28 plasmid containing the LasR-LBD. After transfection, cells were grown overnight at 37 °C in LB medium containing 50 µg/mL kanamycin (LB/KAN). After overnight growth cells were plated onto LB/KAN agar plates at 37 °C.
Cells transfected with empty pET 28 plasmid dealt as controls.
For overexpression of LasR-LBD a single colony of the transfected BL21 cells was transferred into liquid LB/KAN and grown overnight at 37 °C. The next morning the overnight culture was diluted 1:100 into fresh medium, aliquoted into smaller volumes, protected from light and 25 µM of probe or control solution was added. The cells were then incubated at 37 °C until they reached an OD 600~0 .6. At this point 0.4 mM IPTG was added to each cell culture and the plasmid was induced at 21 °C over night. The following morning cells were pelleted for 25 minutes at 4000 rpm. The supernatant was discarded and the pellet washed once with PBS. Again the supernatant was discarded and the pellet was re-suspended in 3 mL fresh PBS. Cell cultures were then transferred into 5 mL petri dishes and UV irradiated at 365 nm for 10 minutes. Thereafter, ~1-2 mg lysozyme and protease inhibitor were added to each cell suspension and cells were lysed by sonication for a total of 2 minutes in cycles of 20" pulses, interspersed with 40" cooling. After sonication the crude lysate was centrifuged for 25 minutes at 4000 rpm at 4 °C. The supernatant was transferred into a fresh tube and kept at 4 °C or for longer storage at -20 °C. 
CLICK chemistry using rhodamine azide (RhN 3 )
To get a relative estimate of protein concentration and allow a fair comparison between samples we took 10 µL of each sample to use in a BCA protein assay (Pierce®BCA Protein Assay Kit; THERMO Scientific, Rockford, IL). To label proteins that covalently bound probes 2-4, we then set up a click reaction between the alkyne present on our probes and Rhodamine azide (RhN 3 ).
According to the sample with the lowest protein concentration samples were diluted in PBS (no less than 1:10), to a total volume of 89 µL. To this volume of sample we then added 50 µM RhN 3 (from a 50 mM stock in DMSO), 1 mM tris(2-carboxyethyl)phosphine (TCEP; from a 50 mM solution prepared fresh every time in DDW), 100 µM tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA, from a 1.7 mM stock in 1:5 DMSO:n-butanol). Samples were briefly mixed before adding CLICK chemistry using biotin azide (Biotin-N 3 ) and affinity purification using streptavidin agarose.
To label proteins that covalently bind the diazirine alkyne C12 probes, and affinity purify them using streptavidin agarose beads (Invitrogen Corp., Grand Island, NY) we set up a click reaction between the alkyne present on our probes and azide-PEG3-Biotin Conjugate (Jena Bioscience GmbH, Jena, Germany). According to the sample with the lowest protein concentration samples were diluted in PBS (used as undiluted as possible), to a total volume of 870 µL. To this volume of sample we then added 150 µM biotin-N 3 (from a 5 mM stock in DDW), 1 mM TCEP, 100 µM TBTA. Then the samples were briefly mixed before adding 1 mM CuSO 4 . After a final brief vortex, samples were incubated over night at RT under constant agitation. For Western Blot analysis samples were eluted adding 300 µL reducing SDS-PAGE sample running buffer and heating samples for 10 minutes at 60 °C, then washing them once with 300 µL PBS, before adding another 300 µL loading buffer and heating them to 90 °C for 10 minutes.
All eluted samples were transferred into separate 500 µL Amicon Ultra Centrifugal Filters (10 kDa cut-off; Milipore Corp., Billerica, MA). Samples were concentrated ~50 times (to about 30-40 µL), collected in low protein binding centrifuge tubes and stored at -20 °C until further processing.
Western blotting
After elution with sample loading buffer and concentration, 10 µL sample were diluted 1:1 in PBS.
After adding 2 µL reducing agent, samples were heated to 90 °C for 10 minutes and then loaded onto a NuPAGE® Bis-Tris 12 % Precast Gel (Invitrogen Corp., Grand Island, NY). After 
Synthetic procedures:
5-oxodec-9-ynoic acid (6):
Compound 6 was prepared following a procedure described by Hodgson et al. 1 A stirred solution of 3,4-dihydro-2H-pyran (1.05 gr, 12.5 mmol) in THF (5 mL), was cooled to -78 °C followed by dropwise addition of t-BuLi (7.3 mL of a 1.7 M solution in pentane, 12.5 mmol) via syringe. The solution was warmed to 5 °C over 1 h before being recooled to -78 °C. Commercially available 5-iodo-1-pentynyl)trimethylsilylsilane (5) Anhydrous ammonia (10 mL) was condensed into a roundbottomed flask containing 6 (0.273 g, 1.5 mmol) at dry ice temperature. The mixture was stirred at 35-40 °C for 5 h. The solution was cooled with dry ice, and a solution of hydroxylamine-O-sulfonic acid (0.20 g, 1.84 mmol ) in anhydrous methanol (1.4 mL) was added over a period of 30 minutes. The dry ice bath was removed, and the mixture was refluxed with stirring at -35 °C for 1 h. The ammonia was then allowed to evaporate overnight. The resulting slurry was filtered and the filter cake washed with several portions of methanol. The combined solution was rotary evaporated. The residue of the diaziridine derivative was dissolved in dichloromethane (1 mL) and treated with triethylamine (0.25 mL). A solution of iodine (0.11 g, 1 mmol) in dichloromethane (1.7 mL) was slowly added under stirring until the appearance of a persistent orange-brown coloration. The mixture was chromatographed on a column of silica gel (0 %-15 % EtOAc in DCM) to yield 7 as a yellow oil (0.095 g, 0.49 mmol, 33 % 68.9, 33.0, 32.1, 31.5, 27.9, 22.6, 18.9, 17.8 .
N-((S)-tetrahydro-2-oxofuran-3-yl)-3-oxo-6-(3-(pent-4-ynyl)-3H-diazirin-3-yl)hexanamide (probe 3):
Compound 3 was prepared following procedure described by Amara et al. 174.9, 166.2, 83.3, 69.9, 65.9, 49.0, 48.5, 42.6, 31.9, 31.4, 29.6, 28.0, 22.6, 17.8, 17.5. HRMS: C 16 
Synthesis of 7-(3-(but-3-ynyl)-3H-diazirin-3-yl)-N-(S)-(2-oxo-tetrahydrofuran-3-yl)-3-oxoheptanamide (probe 4):

6-(tetrahydro-2H-pyran-2-yloxy)hexanoic acid (9):
A solution of 1.8 gr (13.6 mmol) of hydroxycaproic acid 8 in dry dichloromethane (15 mL) was stirred at RT under nitrogen and 32.5 mg of pyridinium p-toluenesulfonate was added, followed by drop wise addition of dihydropyran (1.3 mL, 17.1 mmol). The mixture was stirred at ambient temperature o/n. After solvent evaporation, the reaction mixture was diluted with 30 mL ethyl acetate. The mixture was extracted with aqueous sodium hydroxide ( 1 M; 2*20 mL). The combined sodium hydroxide extracts were acidified with concentrated hydrochloric acid, and extracted with ethyl acetate. The combined organic extracts were dried under MgSO 4 , concentrated under reduced pressure and purified by silica gel chromatography ( 0 % -15 % EtOAc in hexanes) to yield 9 as a yellowed oil (1.0 g, 4.6 mmol, 34 % 
tert-butyl 3-oxo-8-(tetrahydro-2H-pyran-2-yloxy)octanoate (10):
A: To a solution of 6-(Tetrahydro-2H-pyran-2-yloxy)hexanoic acid 9, (2.0 g , 9.2 mmol) in dry dichloromethane (21 mL) under argon, CDI (1.7 gr, 10 mmol) was added at RT. The mixture was stirred at RT for 4 hours, then the solvent was evaporated and the mixture was diluted with dry THF (21 mL).
B: To a solution of mono-tert-butyl malonate (1.7 mL) in dry THF (21 mL) at 0 ºC under argon, isopropyl magnesium chloride (2M in THF, 10.4 mL, 21 mmol) was added dropwise. After 30 minutes at 0 ºC the solution was heated at 50 ºC for 30 minutes, then was cooled again at 0 ºC and solution A was added via cannula. The mixture was left at RT and was stirred o/n, then was quenched with dilute HCl (25 mL) and aqueous phase was extracted with ethyl acetate (2*25 mL).
The combined organic fractions were extracted with NaOH (1 M, 33 mL). The organics were dried over MgSO 4 , concentrated under reduced pressure and purified by silica gel chromatography ( 0 % -15 % EtOAc in hexanes) to yield 10 as a yellowed oil (1.52 g, 4.85 mmol, 52 % 166.4, 98.8, 81.8, 67.2, 62.3, 50.6, 42.7, 30.7, 29.4, 27.9, 25.7, 25.4, 23.2, 19.6 
tert-butyl 3-oxo-2-(prop-2-ynyl)-8-(tetrahydro-2H-pyran-2-yloxy)octanoate (11):
Compound 10 ( 1.52 g, 4.85 mmol) was dissolved in 10 mL dry THF and stirred. Under argon atmosphere NaH (111 mg, 4.6 mmol) was added carefully and stirred for 3 hours. Propargyl bromide (0.550 mL, 80 wt. % solution in toluene, 3.7 mmol) was diluted with 0.55 mL THF and added to a stirred solution during 5 hours. After completion of the reaction, unreacted NaH was neutralized with water, reaction mixture was acidified with 2-3 drops of concentrated HCl, extracted with ethyl acetate (2*20 mL), dried over MgSO 4 , concentrated under reduced pressure and purified by silica gel chromatography ( 0% -15% EtOAc in hexanes) to yield 11 as a yellowed oil (0.70 g, 2.0 mmol, 41 % 167.2, 98.9, 82.6, 80.8, 70.0, 67.3, 62.4, 58.5, 42.5, 30.7, 29.6, 27.9, 25.8, 25.5, 23.3, 19.7, 17.4 
tert-butyl 8-hydroxy-3-oxo-2-(prop-2-ynyl)octanoate (12):
A solution of THP ether 11 (0.58 g, 1.7 mmol) and pyridinium p-toluenesulfonate (6 mg, 0.02 mmol) in ethanol (2 mL) was stirred at 55 ºC for 3 hours. The solvent was evaporated in vacuo, and the residue was chromatographed on a silica gel colounm (EtOAc : hexanes, 1:1 ratio) to yield 12 as a yellowed oil (0.39 g, 1.5 mmol, 88 % 
7-(tert-butoxycarbonyl)-6-oxodec-9-ynoic acid (13):
Jones reagent was added to a stirred solution of compound 12 (0.39 g, 1.5 mmol) in acetone (1.5 mL), with external cooling until the orange colour of the oxidant persisted. After the addition was complete, the reaction was stirred at RT for 30 min, and then diluted with water (5 mL). The aqueous mixture was extracted with ether and the combined ethereal extracts back extracted with aqueous sodium hydroxide (1 M ; 2 x 35 mL). The combined sodium hydroxide extracts were acidified with concentrated hydrochloric acid, and extracted with ether. The combined etheral extracts were dried under MgSO 4 , concentrated under reduced pressure and purified by silica gel chromatography ( EtOAc : DCM, 2:8) to yield 13 as a white solid (0.26 g, 0.9 mmol, 62 % 82.6, 80.6, 70.0, 58.3, 42.0, 33.6, 27.8, 23.9, 22.6, 17.3 
6-oxodec-9-ynoic acid (14):
Compound 13 (0.26 g, 0.9 mmol) was disolved in trifluoroacetic acid (1.5 mL) and stirred for 20 minutes. The trifluooracetic acid was evaporated and the crude was purified by silica gel chromatography (10 % -50 % EtOAc in hexanes) to yield 14 as a white solid (0.09 g, 0.5 mmol, 55 % 205.7, 174.9, 166.3, 82.8, 69.2, 66.0, 49.1, 48.4, 43.4, 32.4, 32.3, 29.8, 28.0, 23.2, 22.7, 13.3. ESI: C 16 Mass spectra of the probes 3-4 were obtained using an LTQ XL Orbitrap ETD with nano ESI (Thermo). Other intermediates (5-15) were analyzed using an LCQ Fleet mass spectrometer (Thermo Scientific) with ESI source, connected to a Surveyor Plus HPLC System (Thermo Scientific). Spectra were collected in positive ion mode and analyzed by Xcalibur software (Thermo Scientific). Mouse macrophage RAW264.7 cells were incubated for 5 hours at 37°C with LPS (10 ng/ml), together with either probe 2 or C12 (0, 10, 25 or 50 µM). IL-10 secretion was measured by ELISA. Each data point represents the mean ± S.D. (n=6), relative to treatment with LPS alone. IL-10 production in resting cells or by C12 or probe 2 alone was undetectable (< 40 pg/ml).
Mouse RAW264.7 macrophage cells, obtained from American Type Culture Collection (ATCC, Rockville, MD), were grown to 80-90% confluence in DMEM medium supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and 1250 U/ml nystatin (hereafter culture medium), and with 10% FBS, at 37°C in a humidified incubator with 5% CO 2 . The cells were maintained for 48 hours prior to the experiment in 96-well plates, at 1.5·10 5 cells per well, in culture medium supplemented with 5% FBS, up to a confluence of 90%. The culture medium was replaced 2 hours before treatment in order to avoid an artifact on signaling caused by medium replacement. Following a 5 hours treatment with Lipopolysaccharide (LPS; Escherichia coli serotype 055:B5) and either C12 or probe 2, IL-10 secretion to the medium was measured by ELISA using reagents sets, according to the manufacturer's instructions, and a microplate reader (Bio-Tek, Winooski, Vermont). 
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